243 related articles for article (PubMed ID: 22786569)
1. Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study.
Toh R; Ishida T; Nishimura K; Nonaka H; Inoue Y; Kitagawa Y; Suematsu M; Miki T; Emoto N; Hirata K
Hypertens Res; 2012 Nov; 35(11):1080-6. PubMed ID: 22786569
[TBL] [Abstract][Full Text] [Related]
2. Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
Wright RF; Duprez D; Purkayastha D; Samuel R; Ferdinand KC
J Clin Hypertens (Greenwich); 2011 Aug; 13(8):588-97. PubMed ID: 21806769
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy.
Kim KS; Fan WH; Kim YD; Zhu W; Ngau YY; Tong P; Kim BS; Santos M; Lin WH; Buranakitjaroen P; Massaad R; Smith RD;
Hypertens Res; 2009 Jun; 32(6):520-6. PubMed ID: 19390542
[TBL] [Abstract][Full Text] [Related]
4. A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome.
Racine N; Hamet P; Sampalis JS; Longo N; Bastien N
J Hum Hypertens; 2010 Nov; 24(11):739-48. PubMed ID: 20147971
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of combination therapy of high-dose losartan and hydrochlorothiazide in patients with hypertension.
Shiga Y; Miura S; Norimatsu K; Hitaka Y; Nagata I; Koyoshi R; Morii J; Kuwano T; Uehara Y; Inoue A; Shirotani T; Fujisawa K; Matsunaga E; Saku K
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1078-84. PubMed ID: 25143336
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and effect on plasma B-type natriuretic peptide concentration of losartan-hydrochlorothiazide for hypertension uncontrolled by losartan-based therapy: subanalysis of a Multicentre Prospective Observational Study.
Meno H; Inou T; Tanaka M; Tsuchiya Y; Shiga Y; Kobayashi K; Nakamura Y; Ota T; Kubara I
Arzneimittelforschung; 2012 Sep; 62(9):414-9. PubMed ID: 22773432
[TBL] [Abstract][Full Text] [Related]
7. The velocity of antihypertensive effect of losartan/hydrochlorothiazide and angiotensin II receptor blocker.
Metoki H; Ohkubo T; Kikuya M; Asayama K; Inoue R; Obara T; Hirose T; Sato M; Hashimoto T; Imai Y;
J Hypertens; 2012 Jul; 30(7):1478-86. PubMed ID: 22573119
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: losartan/hydrochlorothiazide vs. candesartan/amlodipine.
Shimosawa T; Gohchi K; Yatomi Y; Fujita T
Hypertens Res; 2007 Sep; 30(9):831-7. PubMed ID: 18037776
[TBL] [Abstract][Full Text] [Related]
9. Long-term antihypertensive efficacy of losartan/hydrochlorothiazide combination therapy on home blood pressure control.
Miyagawa S; Yamada H; Matsubara H
Clin Exp Hypertens; 2012; 34(6):439-46. PubMed ID: 22471874
[TBL] [Abstract][Full Text] [Related]
10. Effects of losartan/hydrochlorothiazide treatment, after change from ARB at usual dosage, on blood pressure and various metabolic parameters including high-molecular weight adiponectin in Japanese male hypertensive subjects.
Hirose H; Kawabe H; Saito I
Clin Exp Hypertens; 2011; 33(1):41-6. PubMed ID: 21142812
[TBL] [Abstract][Full Text] [Related]
11. Losartan/hydrochlorothiazide combination therapy surpasses high-dose angiotensin receptor blocker in the reduction of morning home blood pressure in patients with morning hypertension.
Hanayama Y; Uchida HA; Nakamura Y; Makino H
Acta Med Okayama; 2012; 66(6):449-59. PubMed ID: 23254579
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
Oparil S; Aurup P; Snavely D; Goldberg A
Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890
[TBL] [Abstract][Full Text] [Related]
13. Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: results after 1 year.
Sato N; Saijo Y; Sasagawa Y; Morimoto H; Takeuchi T; Sano H; Koyama S; Takehara N; Morita K; Sumitomo K; Maruyama J; Kikuchi K; Hasebe N;
J Hypertens; 2013 Jun; 31(6):1245-55. PubMed ID: 23492647
[TBL] [Abstract][Full Text] [Related]
14. Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension.
Ito H; Ishii K; Kihara H; Kasayuki N; Nakamura F; Shimada K; Fukuda S; Iwakura K; Yoshikawa J;
Hypertens Res; 2012 Jan; 35(1):93-9. PubMed ID: 22011686
[TBL] [Abstract][Full Text] [Related]
15. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
Duprez D; Ferdinand K; Purkayastha D; Samuel R; Wright R
Vasc Health Risk Manag; 2011; 7():701-8. PubMed ID: 22174580
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
[TBL] [Abstract][Full Text] [Related]
18. Losartan/hydrochlorothiazide combination is safe and effective for morning hypertension in Very-Elderly patients.
Uchiwa H; Kai H; Iwamoto Y; Anegawa T; Kajimoto H; Fukuda K; Imaizumi T; Fukumoto Y;
Clin Exp Hypertens; 2018; 40(3):267-273. PubMed ID: 29083936
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes mellitus complicated by hypertension in Japanese patients: switching treatment from high-dose angiotensin II receptor blockers to losartan plus hydrochlorothiazide.
Yamamoto S; Okada Y; Mori H; Nishida K; Uriu K; Tanaka Y
Intern Med; 2014; 53(12):1283-9. PubMed ID: 24930646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
